ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Drug chemical manufacturer Carbogen Amcis is adding to its operations in Bubendorf, Switzerland. There the company has agreed to acquire a GEA Pharma Systems site close to its current headquarters. The 3,360-m2 multistory building includes lab, small-scale production, storage, and office space. Carbogen intends to convert more of the facility into regulatory compliant operations for highly potent compound development. The company also plans to add manufacturing of antibody-drug conjugates.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X